Rising prevalence of hypothyroidism and increasing awareness about the following disease to foster the growth of the Global Hashimoto’s Thyroiditis Diagnosis and Treatment Market.
Published: May 2021
The global Hashimoto’s Thyroiditis Diagnosis and Treatment Market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The key factor to drive the market growth is the increasing prevalence of hypothyroidism among the population. For instance, Hashimoto thyroiditis also known as lymphocytic thyroiditis is the major cause of hypothyroidism in the US where it is mostly seen in women in the region.
Growing demand for predictive testing will fuel the demand for genetic testing in the upcoming years
Published: May 2021
The global genetic testing market is projected to grow at a considerable CAGR during the forecast period. Predictive testing is expected to witness significant growth during the forecast period, mainly due to increasing awareness related to available tests.
Global Deodorant Market Growth Aspects
Published: May 2021
The global deodorant market is anticipated to grow significantly at a CAGR of 3.8% over the forecast period (2021-2027). The key aspect that drives the growth of the global deodorant market includes changing the lifestyle of the people and focus on personal hygiene products.
Properties Possessed by Dimethyl Carbonate (DMC) to Drive the Global DMC Market Growth
Published: May 2021
Dimethyl Carbonate (DMC) is an organic compound that is classified under the carbonate ester. It is a colorless and flammable liquid used as a methylating agent and as a solvent that is exempt from the limitations on most volatile organic compounds. The DMC is also considered to be a green reagent.
Rising Prevalence of Various Disorders to Create Scope for the US Interleukin Inhibitors Market Growth
Published: May 2021
The US Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 11.0% over the forecast period (2021-2027). The key aspect that drives the growth of the US Interleukin Inhibitors market includes the rise in the prevalence of arthritis, asthma, eczema, inflammatory bowel disease (IBD), psoriasis, and others.
UK Interleukin Inhibitors Market Segmental Analysis
Published: May 2021
The UK Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 10.7% over the forecast period (2021-2027). The UK Interleukin Inhibitors market is segmented on the basis of product type and applications. Based on the product type, the market is segmented as IL-1 inhibitors, IL-5 inhibitors, IL-6 inhibitors, IL-17 inhibitors, and IL-23 inhibitors.
Rising Prevalence of Psoriasis to Create Scope for North America Interleukin Inhibitors Market
Published: May 2021
The North America Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 11.1% over the forecast period (2021-2027). The US and Canada are the two economies contributing to the growth of the market over the forecast period.
European Interleukin Inhibitors Market Growth Aspects
Published: May 2021
The European Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 10.8% over the forecast period (2021-2027). The UK, Germany, France, Italy, Spain, and the Rest of Europe are the key economies contributing to the growth of the market over the forecast period.
Geriatric Population Creates Scope for the Asia-Pacific Interleukin Inhibitors Market Growth
Published: May 2021
The Asia-Pacific Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 10.9% over the forecast period (2021-2027). China, India, Japan, ASEAN, South Korea, and the Rest of Asia-Pacific are the key economies contributing to the growth of the market over the forecast period.
Global Interleukin Inhibitors Market Segmental Breakdown
Published: May 2021
The global Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 11.2% over the forecast period (2021-2027). The global Interleukin Inhibitors market is segmented on the basis of product type and applications. Based on the product type, the market is segmented as IL-1 inhibitors, IL-5 inhibitors, IL-6 inhibitors, IL-17 inhibitors, and IL-23 inhibitors.